Vaccine Information: FLUZONE High-Dose Quadrivalent Northern Hemisphere (Page 4 of 4)

PRINCIPAL DISPLAY PANEL — 0.7 mL Syringe Label

SANOFI PASTEUR

7760

NDC 49281-121-88

0.7 mL Single-Dose
IM only
Influenza Vaccine
Fluzone® High-Dose
Quadrivalent
2021-2022 Formula
For 65 yrs of age and olderMfd by: Sanofi Pasteur Inc.

Rx only

Fluzone® HD QIV/NDC 49281-121-88

PULL

Principal Display Panel -- 0.7 mL Syringe Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 Syringe Package

NDC 49281-121-65
For Intramuscular
Injection Only

2021–2022 Formula
10 Single-Dose
Prefilled Syringes
0.7 mL each

Rx only

Influenza Vaccine
Fluzone® High-Dose
Quadrivalent

FOR ADULTS65+

SANOFI PASTEUR

Principal Display Panel -- 10 Syringe Package
(click image for full-size original)
FLUZONE HIGH-DOSE QUADRIVALENT NORTHERN HEMISPHERE influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/tasmania/503/2020 ivr-221 (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), and influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) injection, suspension
Product Information
Product Type VACCINE Item Code (Source) NDC:49281-121
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)) INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug in 0.7 mL
INFLUENZA A VIRUS A/Tasmania/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (INFLUENZA A VIRUS A/Tasmania/503/2020 IVR-221 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)) INFLUENZA A VIRUS A/Tasmania/503/2020 IVR-221 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug in 0.7 mL
INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) (INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)) INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug in 0.7 mL
INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) (INFLUENZA B VIRUS B/WASHINGTON/02/2019 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)) INFLUENZA B VIRUS B/WASHINGTON/02/2019 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug in 0.7 mL
Inactive Ingredients
Ingredient Name Strength
GELATIN, UNSPECIFIED
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Water
OCTOXYNOL-9
FORMALDEHYDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49281-121-65 10 SYRINGE, GLASS in 1 PACKAGE contains a SYRINGE, GLASS (49281-121-88)
1 NDC:49281-121-88 0.7 mL in 1 SYRINGE, GLASS This package is contained within the PACKAGE (49281-121-65)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA103914 07/02/2021 06/30/2022
Labeler — Sanofi Pasteur Inc. (086723285)
Establishment
Name Address ID/FEI Operations
Sanofi Pasteur Inc. 086723285 MANUFACTURE (49281-121)

Revised: 07/2021 Sanofi Pasteur Inc.

Page 4 of 4 1 2 3 4

VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Vaccine Sections

Vaccine Information by RSS

As the leading independent provider of trustworthy vaccine information, our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VxLabels.com provides the full vaccine subset of the FDA's repository. Vaccine information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.